Do minimum volume regulations for health care interventions improve the quality of care? A systematic review

Similar documents
Stents for the treatment of intracranial arterial stenosis: VISSIT study and acute treatment in Germany 1

Summary HTA. Drug-eluting stents vs. coronary artery bypass-grafting. HTA-Report Summary. Gorenoi V, Dintsios CM, Schönermark MP, Hagen A

IQWiG Reports - Commission No. A Ezetimibe for hypercholesterolaemia 1. Executive Summary

Concentration and choice in the provision of hospital services: summary report NHS Centre for Reviews and Dissemination

Positron emission tomography (PET and PET/CT) in recurrent colorectal cancer 1

Assessment of the benefit of screening in persons under 55 years of age with a family history of colorectal cancer 1

Present-on-Admission (POA) Coding

Why is co-morbidity important for cancer patients? Michael Chapman Research Programme Manager

LAPAROSCOPIC AORTO-ILIAC SURGERY

Safinamide (Addendum to Commission A15-18) 1

IQWiG Reports Commission No. A05-05C. Executive Summary

Executive Summary. IQWiG Reports Commission No. V06-02C

Promising first experience of endovascular treatment of ruptured abdominal aortic aneurysms

Ultrasound-guided highintensity

PROSPERO International prospective register of systematic reviews

Quality Measures MIPS CV Specific

Outcomes assessed in the review

Recording and Evaluation of Co-Morbidity - An Update. Jill Birch University of Manchester

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

In Pursuit of Excellence: The CheckPoint Journey

MHSPHP Metrics Forum. Diabetes.

BMS vs. DES vs. CABG

Setting The setting was a hospital. The economic study was carried out in Australia.

Idelalisib Benefit assessment according to 35a Social Code Book V 1

DATE: 04 April 2012 CONTEXT AND POLICY ISSUES

Executive Summary. Positron emission tomography (PET and PET/CT) in malignant lymphoma 1. IQWiG Reports Commission No. D06-01A

Why is co-morbidity important for cancer patients? Di Riley Associate Director Clinical Outcomes Programme

Cardiovascular Disease and Commercial Motor Vehicle Driver Safety. Physical Qualifications Division April 10, 2007

Setting The setting was secondary care. The economic study was conducted in Germany.

Executive Summary. Evaluation of the therapeutic benefits and harms of exenatide 1. IQWiG Reports - Commission No. A05-23

FY X Time (48 hrs for cardiac surgery) SCIP-Inf-4 Cardiac Surgery Patients With Controlled 6 A.M. Postoperative Blood

Exceptions to the Rules: Abdominal and Thoracic Aneurysms

Dr Yuen Wai-Cheung HA Convention 2011

Corporate Medical Policy

The American Experience

Experience of endovascular procedures on abdominal and thoracic aorta in CA region

To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events.

Thrombin injection vs Conventional Surgical Repair in Treatment of Iatrogenic Post-cath Femoral Artery Pseudoaneurysm (IFAP)

PROSPERO International prospective register of systematic reviews

Saxagliptin/metformin Benefit assessment according to 35a Social Code Book V 1

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE)

Empagliflozin/metformin

(For items 1-12, each question specifies mark one or mark all that apply.)

Peripheral Vascular Disease

Relationship between surgeon volume and outcomes: a systematic review of systematic reviews

Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity?

Qigong for healthcare: an overview of systematic reviews

Valve Disease. Valve Surgery. Total Volume. In 2016, Cleveland Clinic surgeons performed 3039 valve surgeries.

including prevention, healthy lifestyle behaviors, populations at risk & disparities (age, race/ ethnicity, gender, geographic & socioeconomic)

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Case #4 Diagnosis: Pregnancy at 39 weeks with fetal distress Procedure: This is a 28-year-old patient who had a previous cesarean section for

IQWiG Reports Commission No. A Edoxaban

DENOMINATOR: Patients undergoing endovascular lower extremity revascularization

Endovascular therapy for Ischemic versus Nonischemic complicated acute type B aortic dissection (catbad).

Is EVAS a proper choice in women?

I-Hui Wu, M.D. Ph.D. Clinical Assistant Professor Cardiovascular Surgical Department National Taiwan University Hospital

SUB TOPIC 3 : CLINICAL INDICATORS (CLINICAL QUALITY ASSURANCE CQA)

* PLACE OF SERVICE REQUIREMENTS FOR ADDITIONAL HIGHMARK WV MEDICAL POLICIES ANNOUNCED IN THE FEBRUARY 2011 ISSUE OF PROVIDER NEWS *

Recommendations for Follow-up After Vascular Surgery Arterial Procedures SVS Practice Guidelines

IQWiG Reports Commission No. A Dulaglutide

Surgery for patients with diffuse atherosclerotic disease

SCORES FOR 4 TH QUARTER, RD QUARTER, 2014

Endovascular versus 'fast-track' abdominal aortic aneurysm repair Abularrage C J, Sheridan M J, Mukherjee D

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

VASCULAR SURGERY ROTATION (PGY 3)

Measure #164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clinical Care

SAMPLE Data Entry Manual for the veds Project

Health Economics & Decision Science (HEDS) Discussion Paper Series

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Title: A note on the graphical presentation of prediction intervals in random effects meta-analysis

Endovascular Repair o Abdominal. Aortic Aneurysms. Cesar E. Mendoza, M.D. Jackson Memorial Hospital Miami, Florida

ASA PLAVIX AND PREOPERATIVE OPTIMIZATION. John Hann, MD

Perampanel Benefit assessment according to 35a Social Code Book V 1

Perioperative Cardiovascular Evaluation and Care for Noncardiac. Dr Mahmoud Ebrahimi Interventional cardiologist 91/9/30

Supplementary Information

El equilibrio entre regulación-innovación en la fijación de precios y financiación de medicamentos OR The AMNOG Law

ENCORE, a Study to Investigate the Durability of Polymer EVAR with Ovation A Contemporary Review of 1296 Patients

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE

CADTH Therapeutic Review

Cardiovascular Medicine Fellowship Vascular Rotation Goals and Objectives Goals and Objectives LEVEL I Medical Knowledge

Delineation Of Privileges Vascular Surgery Privileges

Appendix 1: Supplementary tables [posted as supplied by author]

9/30/13. PAP Therapy for OSA in the Perioperative Setting: Is There a Best Approach? Financial Disclosures

Addendum to Commission A12-02 Rilpivirine/emtricitabine/ tenofovir 1

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Executive Summary. Different antihypertensive drugs as first line therapy in patients with essential hypertension 1

2016 Re-Audit of Patient Blood Management in adults undergoing elective, scheduled surgery

Sofosbuvir/velpatasvir (chronic hepatitis C)

PQRS 2015Applicable Measure Group Codes ICD-9 and ICD-10 diagnosis codes and CPT encounter and surgical codes

Benefits and Harms of Routine Preoperative Testing: A Comparative Effectiveness Review

Balloon angioplasty versus bypass grafting in the era of coronary stenting Ekstein S, Elami A, Merin G, Gotsman M S, Lotan C

LECTURES AND SEMINARS SCHEDULE SURGERY

Biomarker-based tests to support the decision for or against adjuvant systemic chemotherapy in primary breast cancer

Outcome of elderly patients with severe but asymptomatic aortic stenosis

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Intraoperative application of Cytosorb in cardiac surgery

Technical Appendix for Outcome Measures

Transcription:

Do minimum volume regulations for health care interventions improve the quality of care? A systematic review 2 nd Conference of International Society for EBHC October 30 th November 2 nd Ulrich Siering, Corinna Ernsting, Wiebke Hoffmann-Eßer, Susanne Ein Waldt, Ulrich Grouven, Anke Schulz, Siw Waffenschmidt, Alric Rüther Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany

Background The association between the volume of health care interventions and health care outcomes has been discussed controversially in the literature for more than 30 years. Several studies show an association between the volume of health care interventions and health care outcomes. It is uncertain whether the determination of a minimum volume for a health care intervention as a regulatory measure leads to better health care outcomes Objective To systematically review the literature on the effects of minimum volume regulations on health care outcomes. Siering, Ernsting, Hoffmann-Eßer, Ein Waldt, Grouven, Schulz, Waffenschmidt, Rütherr - Minimum volume regulations 2

Definitions Threshold A certain volume for a specific health care intervention above which better outcomes relating to relevant quality indicators can be achieved, or A certain volume for a specific health care intervention that divides high from low quality providers. Minimum volume Determination of certain number of patients with a particular indication or determination of a minimum volume for a specific health care intervention per provider and year. Minimum volume regulation Determination of a minimum volume for a specific health care intervention as a regulatory measure Siering, Ernsting, Hoffmann-Eßer, Ein Waldt, Grouven, Schulz, Waffenschmidt, Rütherr - Minimum volume regulations 3

Information retrieval Literature search search in MEDLINE, EMBASE and the Cochrane Library additionally: search via the Related Citations function in MEDLINE and screening of reference lists of included publications Main inclusion criteria study investigates the quality-assuring effects of minimum volume regulations on health care outcomes study reports patient-relevant outcomes such as mortality, morbidity and health-related quality of life English- or German-language publication published after 2000 Siering, Ernsting, Hoffmann-Eßer, Ein Waldt, Grouven, Schulz, Waffenschmidt, Rütherr - Minimum volume regulations 4

Results: Information retrieval Siering, Ernsting, Hoffmann-Eßer, Ein Waldt, Grouven, Schulz, Waffenschmidt, Rütherr - Minimum volume regulations 5

Study characteristics Date of publication Between 2007 and 2011 Country Germany: 3 studies USA: 2 studies Canada: 1 study Sector Inpatient: all studies Outpatient: - Data source Administrative data from hospitals: 3 studies Data from quality assurance programs: 3 studies Additional hospital survey: 1 study Before and after the introduction of a minimum volume regulation: 5 studies Observation period Between 3 and 10 years Comparison Regional comparison: 1 study Regional + before & after: 1 study Siering, Ernsting, Hoffmann-Eßer, Ein Waldt, Grouven, Schulz, Waffenschmidt, Rütherr - Minimum volume regulations 6

Procedures, diseases and main outcomes Author / Country Procedures / diseases Main outcomes Geraedts 2008 / Germany Ho 2004 / USA Kostuj 2011 / Germany Masserweh 2011 / USA Ohmann 2010 / Germany Total knee replacement (TKR) Percutaneous transluminal coronary angioplasty (PTCA) Total knee replacement (TKR) Abdominal aortic aneurysm (AAA) repair; oesophageal (OES) and pancreatic (PAN) surgical interventions Total knee replacement (TKR) Mortality: Morbidity: Mortality: Morbidity: Mortality: Morbidity: Mortality: Morbidity: Mortality: Morbidity: no no Simunovic 2010 / Canada Pancreatic (PAN) surgical interventions Mortality: Morbidity: no Siering, Ernsting, Hoffmann-Eßer, Ein Waldt, Grouven, Schulz, Waffenschmidt, Rütherr - Minimum volume regulations 7

Quality of included studies Study design? Retrospective observational study: All studies Sufficient presentation of the data in the studies? Sufficient: 4 studies Insufficient: 2 studies Adequate statistical model used? Yes: all studies No: - Risk adjustment? Yes: all studies No: - Consideration of cluster effects? Yes: 4 studies Unclear: 1 study No: 1 study Information on model quality? Information: 1 study No information: 5 studies Siering, Ernsting, Hoffmann-Eßer, Ein Waldt, Grouven, Schulz, Waffenschmidt, Rütherr - Minimum volume regulations 8

Results: Mortality Author Procedures Outcome Statistically significant results Ho 2004 PTCA In-hospital mortality no significant changes Kostuj 2011 TKR In-hospital mortality no significant changes Masserweh 2011 Simunovic 2010 AAA repair no significant changes OES 30-/90-day mortality no significant changes PAN no significant changes PAN surgical mortality significant reduction AAA repair: abdominal aortic aneurysm repair; OES: oesophageal surgical interventions; PAN: pancreatic surgical interventions; PTCA: percutaneous transluminal coronary angioplasty; TKR: total knee replacement Siering, Ernsting, Hoffmann-Eßer, Ein Waldt, Grouven, Schulz, Waffenschmidt, Rütherr - Minimum volume regulations 9

Results: Morbidity Author Procedure Outcome Statistically significant results Geraedts 2008 TKR Postoperative wound infection no significant changes Ho 2004 PTCA Emergency CABG [no details provided] Kostuj 2011 TKR Wound infection; cardiovascular events no significant changes Ohmann 2010 Masserweh 2011 TKR AAA repair Pneumonia; thrombosis; pulmonary embolism; vascular and neural lesions Fractures; implant malpositioning Postoperative wound infection; postoperative hematomas / secondary bleeding 30-day complications significant reduction significant increase significant reduction significant reduction OES 30-day complications no significant changes PAN 30-day complications significant increase AAA repair: abdominal aortic aneurysm repair; CABG: coronary artery bypass surgery; OES: oesophageal surgical interventions; PAN: pancreatic surgical interventions; PTCA: percutaneous transluminal coronary angioplasty; TKR: total knee replacement Siering, Ernsting, Hoffmann-Eßer, Ein Waldt, Grouven, Schulz, Waffenschmidt, Rütherr - Minimum volume regulations 10

Results: Health-related quality of life None of the included studies considered the outcome health-related quality of life. Siering, Ernsting, Hoffmann-Eßer, Ein Waldt, Grouven, Schulz, Waffenschmidt, Rütherr - Minimum volume regulations 11

Conclusions The regulation of minimum volumes of health care interventions is being discussed as an option to improve health care outcomes. We identified 6 studies mostly of low methodological quality investigating the effects of minimum volume regulations on health care outcomes. The studies showed contradictory effects for the outcomes mortality and morbidity. None of the included studies considered the outcome healthrelated quality of life. It has been insufficiently investigated whether minimum volume regulations actually lead to an improvement in the quality of health care. Further research is needed to be able to draw robust conclusions on the quality-assuring effects of minimum volume regulations. Siering, Ernsting, Hoffmann-Eßer, Ein Waldt, Grouven, Schulz, Waffenschmidt, Rütherr - Minimum volume regulations 12

Institute for Quality and Efficiency in Health Care (IQWiG) Im Mediapark 8 50670 Cologne Germany Telefon +49-221/3 56 85-0 Telefax +49-221/3 56 85-1 ulrich.siering@iqwig.de www.iqwig.de Photo: http://img.fotocommunity.com/images/koeln-rhein-erftkreis/koeln/koelnturm-im-mediapark-a24731976.jpg Siering, Ernsting, Hoffmann-Eßer, Ein Waldt, Grouven, Schulz, Waffenschmidt, Rütherr - Minimum volume regulations 13